Please sign in to follow a disease.

NR-axspa

Clinical trials for NR-axspa explained in plain language.

Never miss a new study

Get alerted when new NR-axspa trials appear

Sign up with your email to follow new studies for NR-axspa, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.

Vår säkerhetsrekommendation!

Genom att skicka in godkänner du våra Användarvillkor

Not yet recruiting 1 Completed 1

New drug shows promise for Long-Term control of back pain condition

Disease control Completed

This study is testing the long-term safety and effectiveness of bimekizumab, a drug that reduces inflammation, in 508 adults with active axial spondyloarthritis (including ankylosing spondylitis). Participants who completed earlier trials will receive the drug for an extended per…

Matched conditions: NR-AXSPA

Phase 3 • Sponsor: UCB Biopharma SRL • Aim: Disease control

Last updated Sep 12, 2026 00:00 UTC

NR-axspa

Get alerted when new NR-axspa trials appear

New drug shows promise for Long-Term control of back pain condition